作物における遺伝子編集市場：技術プラットフォーム別、作物タイプ別、送達方法、用途別、エンドユーザー別 - 20251年～2030年の世界予測

作物における遺伝子編集市場は、2024年には24億9,000万米ドルとなり、2025年には27億6,000万米ドルで、CAGR11.47%で成長し、2030年までには47億7,000万米ドルに達すると予測されています。

食糧安全保障を強化し持続可能な農業変革を推進する遺伝子編集技術を通じて作物イノベーションの最前線を探る

精密な遺伝子編集技術の出現は、農業科学における極めて重要な瞬間であり、世界的な食糧安全保障の課題に対処する前例のない機会を提供するものです。世界の人口が増え続け、気候がより予測不可能になるにつれ、伝統的な育種方法だけでは、現代社会が求める収量、回復力、栄養の質の急速な向上を実現することはできません。CRISPRベースのシステム、塩基編集、プライム編集などの遺伝子編集プラットフォームは、研究者や開発者が利用できるツールキットを再定義し、主要な作物形質の正確かつ効率的でコスト効率の高い改変を可能にしています。

農業における画期的な革新と進化する規制力学を通じて、作物遺伝学を再形成するパラダイムシフトを解き明かす

過去10年間、農業セクターは、分子生物学のブレークスルー、データ解析の進歩、そして規制の優先順位の変化により、一連の変革的シフトを経験してきました。CRISPR-Casツールの急速な改良と次世代編集システムの出現は、新規作物品種の開発ペースを加速させました。これと並行して、より健康的で栄養価の高い農産物に対する消費者の要求が高まっているため、企業はゲノム編集を自社の製品パイプラインに組み込み、ビタミンレベルの向上や風味プロファイルの改善といった形質をターゲットにするようになっています。

米国の新たな関税が遺伝子編集作物開発のサプライチェーンと世界貿易の流れに及ぼす遠大な影響の評価

2025年、米国による新たな関税措置の導入は、遺伝子組換え種子と関連インプットのグローバルサプライチェーンを再編成する可能性があります。輸入試薬、特殊酵素、カスタムデリバリーシステムに追加関税を課すことで、これらの政策は国内外の利害関係者の研究開発コストを引き上げる可能性があります。その結果、企業は生産拠点、調達戦略、提携契約を見直し、費用の上昇を緩和する可能性があります。

遺伝子編集作物市場を包括的な戦略的多次元セグメンテーションレンズで解剖し、実用的な洞察を得る

遺伝子編集作物市場は、多角的な分析により、それぞれの価値ドライバーと投資の優先順位に光を当てることができます。技術プラットフォームのレンズを通して見ると、そのスペクトルは塩基編集やプライム編集からCRISPRベースのシステム、メガヌクレアーゼ、部位特異的ヌクレアーゼ、転写活性化因子様エフェクターヌクレアーゼ、ジンクフィンガーヌクレアーゼにまで及び、それぞれが精度とオフターゲットリスク管理においてユニークな利点を提供しています。作物タイプに焦点を移すと、穀類、果実・野菜、豆類・豆類、油糧作物で、収量、病害虫抵抗性、栄養成分を目的とした遺伝子強化にさまざまに反応する、差別化された機会が明らかになります。

世界の主要地域における遺伝子編集作物導入の地域動態をマッピングし、戦略的成長機会を発見する

各地域の市場力学を見ると、規制アプローチ、調査強度、採用率がそれぞれ異なっていることがわかります。南北アメリカでは、主要市場における民間部門の旺盛な投資と合理化された規制経路により、遺伝子編集作物品種の商業化が加速しています。逆に、欧州、中東・アフリカでは、厳格な安全性評価による慎重な姿勢と、気候変動への耐性を高める形質開発に重点を置く研究ハブにおけるイノベーションのポケットが共存しています。

先駆的な調査とパートナーシップを通じて遺伝子編集作物のエコシステムを形成している主要なイノベーターと戦略的協力者を紹介する

遺伝子編集作物分野の主要組織は、多様な研究パイプラインと戦略的提携を通じてイノベーションを体現しています。既存の農業バイオテクノロジー企業は、分子育種における数十年の専門知識を活用して遺伝子編集ツールを統合し、形質発見と検証を強化するために専門技術プロバイダーと提携を結んでいます。一方、新興のバイオテクノロジー企業は、栄養価の向上や病原菌に対する次世代抵抗性など、インパクトの大きい用途に重点を置いてニッチを開拓しています。

農業における遺伝子編集技術の開発と普及を加速するための戦略的提言で、利害関係者に力を与える

業界利害関係者は、承認経路を合理化し、費用のかかる遅延を回避するため、研究計画に規制情報を早期に統合することを優先すべきです。政策立案者との関係を築き、透明性の高い安全性の枠組みで足並みを揃えることで、より円滑な市場参入が促進され、社会的信頼が構築されます。さらに、ナノ粒子ベースのシステムやリボ核タンパク質複合体のような、拡張性のあるデリバリープラットフォームに投資することで、実地試験までの時間を短縮し、遺伝子組み換えの精度を高めることができます。

作物科学における遺伝子編集革新の包括的分析を支える厳密な調査手法の公開

この分析は、一次情報と二次情報を統合した厳密な調査手法に基づいています。ベテラン研究者、規制専門家、業界幹部との専門家インタビューを実施し、技術的実現可能性、政策展開、商業化戦略に関する微妙な視点を捉えました。これらの定性調査結果は、公表された科学文献、特許出願、政府刊行物と体系的に照合し、深さと正確さの両方を確保しました。

主要な洞察の統合と、持続的イノベーションと食糧安全保障の前進に向けた作物遺伝子編集の将来の軌跡の描出

本エグゼクティブサマリーは、遺伝子編集作物分野における技術の進歩、規制の変化、関税の影響、戦略的セグメンテーションに関する重要な洞察をまとめたものです。多様な編集プラットフォームが進化しつつある政策フレームワークとどのように融合し、回復力、生産性、栄養価を向上させた作物の開発を加速させているかを浮き彫りにしています。本分析は、南北アメリカにおける強固な民間セクターの関与からアジア太平洋における官民協力モデルまで、採用経路を形成する微妙な地域力学を強調しています。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場力学

• 多重遺伝子編集プラットフォームの統合による病害耐性トマトおよびジャガイモ品種の開発
• 主要作物の干ばつ耐性と耐暑性を向上させるためにCRISPRベースエディターの導入を加速
• タンパク質含有量と窒素利用効率の向上を目的とした遺伝子編集大豆の商業化戦略
• トウモロコシの害虫耐性のための正確な遺伝子編集を可能にする組織特異的プロモーター設計の進歩
• 農業バイオテクノロジーにおける遺伝子編集の承認に関する米国、EU、アジア太平洋間の規制調和の取り組み
• 小麦ゲノム編集パイプラインの加速に向けた農業バイオテクノロジーのスタートアップ企業と学術機関の連携
• イネにおける遺伝子編集の最適化に向けた予測表現型解析とAI駆動型ターゲット同定への投資急増

第6章 市場洞察

• ポーターのファイブフォース分析
• PESTEL分析

第7章 米国の関税の累積的な影響、2025年

第8章 作物における遺伝子編集市場：技術プラットフォーム別

• 塩基編集とプライム編集
• CRISPRベースのシステム
• メガヌクレアーゼ
• 部位特異的ヌクレアーゼ
• 転写活性化因子様エフェクターヌクレアーゼ
• ジンクフィンガーヌクレアーゼ

第9章 作物における遺伝子編集市場：作物タイプ別

• 穀物作物
• 果物と野菜
• 豆類
• 油糧作物

第10章 作物における遺伝子編集市場：送達方法別

• アグロバクテリウムによる形質転換
• エレクトロポレーション
• 遺伝子銃
• ナノ粒子ベースの送達
• リボ核タンパク質（RNP）複合体
• ウイルスベクター送達

第11章 作物における遺伝子編集市場：用途別

• 耐病性
  • 細菌耐性
  • 真菌耐性
  • ウイルス耐性
• 干ばつ耐性
• 除草剤耐性
• 栄養強化

第12章 作物における遺伝子編集市場：エンドユーザー別

• 農業バイオテクノロジー企業
• 農家・生産者協会
• 政府・規制機関
• 研究機関・大学
• 種子会社

第13章 南北アメリカの作物における遺伝子編集市場

• 米国
• カナダ
• メキシコ
• ブラジル
• アルゼンチン

第14章 欧州、中東・アフリカの作物における遺伝子編集市場

• 英国
• ドイツ
• フランス
• ロシア
• イタリア
• スペイン
• アラブ首長国連邦
• サウジアラビア
• 南アフリカ
• デンマーク
• オランダ
• カタール
• フィンランド
• スウェーデン
• ナイジェリア
• エジプト
• トルコ
• イスラエル
• ノルウェー
• ポーランド
• スイス

第15章 アジア太平洋の作物における遺伝子編集市場

• 中国
• インド
• 日本
• オーストラリア
• 韓国
• インドネシア
• タイ
• フィリピン
• マレーシア
• シンガポール
• ベトナム
• 台湾

第16章 競合情勢

• 市場シェア分析、2024年
• FPNVポジショニングマトリックス、2024年
• 競合分析
  • AgBiome, Inc.
  • BASF SE
  • Bayer AG
  • Benson Hill, Inc.
  • Calyxt, Inc.
  • Cibus, Inc.
  • Corteva Agriscience, Inc. by DuPont de Nemours, Inc
  • Creative Biogene
  • Elo Life Systems
  • Groupe Limagrain S.A.
  • Inari Agriculture, Inc.
  • KWS SAAT SE & Co. KGaA
  • Origin Agritech
  • Pairwise Foods, Inc.
  • Syngenta AG
  • Yield10 Bioscience, Inc.

第17章 リサーチAI

第18章 リサーチ統計

第19章 リサーチコンタクト

第20章 リサーチ記事

第21章 付録

LIST OF FIGURES

• FIGURE 1. GENE-EDITING IN CROPS MARKET RESEARCH PROCESS
• FIGURE 2. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 3. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 4. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2024 VS 2030 (%)
• FIGURE 6. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY CROP TYPE, 2024 VS 2030 (%)
• FIGURE 8. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY CROP TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY DELIVERY METHOD, 2024 VS 2030 (%)
• FIGURE 10. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY DELIVERY METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
• FIGURE 12. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 13. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
• FIGURE 14. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 15. AMERICAS GENE-EDITING IN CROPS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 16. AMERICAS GENE-EDITING IN CROPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 17. UNITED STATES GENE-EDITING IN CROPS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 18. UNITED STATES GENE-EDITING IN CROPS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GENE-EDITING IN CROPS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GENE-EDITING IN CROPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 21. ASIA-PACIFIC GENE-EDITING IN CROPS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 22. ASIA-PACIFIC GENE-EDITING IN CROPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 23. GENE-EDITING IN CROPS MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 24. GENE-EDITING IN CROPS MARKET, FPNV POSITIONING MATRIX, 2024
• FIGURE 25. GENE-EDITING IN CROPS MARKET: RESEARCHAI
• FIGURE 26. GENE-EDITING IN CROPS MARKET: RESEARCHSTATISTICS
• FIGURE 27. GENE-EDITING IN CROPS MARKET: RESEARCHCONTACTS
• FIGURE 28. GENE-EDITING IN CROPS MARKET: RESEARCHARTICLES

LIST OF TABLES

• TABLE 1. GENE-EDITING IN CROPS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, 2018-2024 (USD MILLION)
• TABLE 4. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, 2025-2030 (USD MILLION)
• TABLE 5. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 6. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
• TABLE 7. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 8. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
• TABLE 9. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
• TABLE 10. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
• TABLE 11. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY BASE EDITING & PRIME EDITING, BY REGION, 2018-2024 (USD MILLION)
• TABLE 12. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY BASE EDITING & PRIME EDITING, BY REGION, 2025-2030 (USD MILLION)
• TABLE 13. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY CRISPR-BASED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 14. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY CRISPR-BASED SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 15. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY MEGANUCLEASES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 16. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY MEGANUCLEASES, BY REGION, 2025-2030 (USD MILLION)
• TABLE 17. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY SITE-DIRECTED NUCLEASES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 18. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY SITE-DIRECTED NUCLEASES, BY REGION, 2025-2030 (USD MILLION)
• TABLE 19. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY TRANSCRIPTION ACTIVATOR-LIKE EFFECTOR NUCLEASES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 20. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY TRANSCRIPTION ACTIVATOR-LIKE EFFECTOR NUCLEASES, BY REGION, 2025-2030 (USD MILLION)
• TABLE 21. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY ZINC FINGER NUCLEASES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 22. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY ZINC FINGER NUCLEASES, BY REGION, 2025-2030 (USD MILLION)
• TABLE 23. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
• TABLE 24. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
• TABLE 25. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY CEREAL CROPS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 26. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY CEREAL CROPS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 27. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY FRUITS & VEGETABLES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 28. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY FRUITS & VEGETABLES, BY REGION, 2025-2030 (USD MILLION)
• TABLE 29. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY LEGUMES & PULSES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 30. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY LEGUMES & PULSES, BY REGION, 2025-2030 (USD MILLION)
• TABLE 31. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY OILSEED CROPS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 32. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY OILSEED CROPS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 33. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
• TABLE 34. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
• TABLE 35. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY AGROBACTERIUM-MEDIATED TRANSFORMATION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 36. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY AGROBACTERIUM-MEDIATED TRANSFORMATION, BY REGION, 2025-2030 (USD MILLION)
• TABLE 37. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY ELECTROPORATION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 38. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY ELECTROPORATION, BY REGION, 2025-2030 (USD MILLION)
• TABLE 39. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY GENE GUN, BY REGION, 2018-2024 (USD MILLION)
• TABLE 40. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY GENE GUN, BY REGION, 2025-2030 (USD MILLION)
• TABLE 41. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY NANOPARTICLE-BASED DELIVERY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 42. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY NANOPARTICLE-BASED DELIVERY, BY REGION, 2025-2030 (USD MILLION)
• TABLE 43. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY RIBONUCLEOPROTEIN (RNP) COMPLEXES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 44. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY RIBONUCLEOPROTEIN (RNP) COMPLEXES, BY REGION, 2025-2030 (USD MILLION)
• TABLE 45. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY VIRAL VECTOR DELIVERY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 46. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY VIRAL VECTOR DELIVERY, BY REGION, 2025-2030 (USD MILLION)
• TABLE 47. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 48. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 49. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY DISEASE RESISTANCE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 50. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY DISEASE RESISTANCE, BY REGION, 2025-2030 (USD MILLION)
• TABLE 51. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY BACTERIAL RESISTANCE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 52. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY BACTERIAL RESISTANCE, BY REGION, 2025-2030 (USD MILLION)
• TABLE 53. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY FUNGAL RESISTANCE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 54. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY FUNGAL RESISTANCE, BY REGION, 2025-2030 (USD MILLION)
• TABLE 55. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY VIRAL RESISTANCE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 56. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY VIRAL RESISTANCE, BY REGION, 2025-2030 (USD MILLION)
• TABLE 57. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY DISEASE RESISTANCE, 2018-2024 (USD MILLION)
• TABLE 58. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY DISEASE RESISTANCE, 2025-2030 (USD MILLION)
• TABLE 59. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY DROUGHT TOLERANCE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 60. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY DROUGHT TOLERANCE, BY REGION, 2025-2030 (USD MILLION)
• TABLE 61. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY HERBICIDE TOLERANCE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 62. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY HERBICIDE TOLERANCE, BY REGION, 2025-2030 (USD MILLION)
• TABLE 63. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY NUTRITIONAL ENHANCEMENT, BY REGION, 2018-2024 (USD MILLION)
• TABLE 64. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY NUTRITIONAL ENHANCEMENT, BY REGION, 2025-2030 (USD MILLION)
• TABLE 65. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 66. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 67. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 68. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
• TABLE 69. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY FARMERS & GROWER ASSOCIATIONS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 70. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY FARMERS & GROWER ASSOCIATIONS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 71. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY GOVERNMENT & REGULATORY BODIES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 72. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY GOVERNMENT & REGULATORY BODIES, BY REGION, 2025-2030 (USD MILLION)
• TABLE 73. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY RESEARCH INSTITUTES & UNIVERSITIES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 74. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY RESEARCH INSTITUTES & UNIVERSITIES, BY REGION, 2025-2030 (USD MILLION)
• TABLE 75. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY SEED COMPANIES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 76. GLOBAL GENE-EDITING IN CROPS MARKET SIZE, BY SEED COMPANIES, BY REGION, 2025-2030 (USD MILLION)
• TABLE 77. AMERICAS GENE-EDITING IN CROPS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
• TABLE 78. AMERICAS GENE-EDITING IN CROPS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
• TABLE 79. AMERICAS GENE-EDITING IN CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
• TABLE 80. AMERICAS GENE-EDITING IN CROPS MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
• TABLE 81. AMERICAS GENE-EDITING IN CROPS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
• TABLE 82. AMERICAS GENE-EDITING IN CROPS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
• TABLE 83. AMERICAS GENE-EDITING IN CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 84. AMERICAS GENE-EDITING IN CROPS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 85. AMERICAS GENE-EDITING IN CROPS MARKET SIZE, BY DISEASE RESISTANCE, 2018-2024 (USD MILLION)
• TABLE 86. AMERICAS GENE-EDITING IN CROPS MARKET SIZE, BY DISEASE RESISTANCE, 2025-2030 (USD MILLION)
• TABLE 87. AMERICAS GENE-EDITING IN CROPS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 88. AMERICAS GENE-EDITING IN CROPS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 89. AMERICAS GENE-EDITING IN CROPS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 90. AMERICAS GENE-EDITING IN CROPS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
• TABLE 91. UNITED STATES GENE-EDITING IN CROPS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
• TABLE 92. UNITED STATES GENE-EDITING IN CROPS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
• TABLE 93. UNITED STATES GENE-EDITING IN CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
• TABLE 94. UNITED STATES GENE-EDITING IN CROPS MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
• TABLE 95. UNITED STATES GENE-EDITING IN CROPS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
• TABLE 96. UNITED STATES GENE-EDITING IN CROPS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
• TABLE 97. UNITED STATES GENE-EDITING IN CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 98. UNITED STATES GENE-EDITING IN CROPS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 99. UNITED STATES GENE-EDITING IN CROPS MARKET SIZE, BY DISEASE RESISTANCE, 2018-2024 (USD MILLION)
• TABLE 100. UNITED STATES GENE-EDITING IN CROPS MARKET SIZE, BY DISEASE RESISTANCE, 2025-2030 (USD MILLION)
• TABLE 101. UNITED STATES GENE-EDITING IN CROPS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 102. UNITED STATES GENE-EDITING IN CROPS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 103. UNITED STATES GENE-EDITING IN CROPS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
• TABLE 104. UNITED STATES GENE-EDITING IN CROPS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
• TABLE 105. CANADA GENE-EDITING IN CROPS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
• TABLE 106. CANADA GENE-EDITING IN CROPS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
• TABLE 107. CANADA GENE-EDITING IN CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
• TABLE 108. CANADA GENE-EDITING IN CROPS MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
• TABLE 109. CANADA GENE-EDITING IN CROPS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
• TABLE 110. CANADA GENE-EDITING IN CROPS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
• TABLE 111. CANADA GENE-EDITING IN CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 112. CANADA GENE-EDITING IN CROPS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 113. CANADA GENE-EDITING IN CROPS MARKET SIZE, BY DISEASE RESISTANCE, 2018-2024 (USD MILLION)
• TABLE 114. CANADA GENE-EDITING IN CROPS MARKET SIZE, BY DISEASE RESISTANCE, 2025-2030 (USD MILLION)
• TABLE 115. CANADA GENE-EDITING IN CROPS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 116. CANADA GENE-EDITING IN CROPS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 117. MEXICO GENE-EDITING IN CROPS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
• TABLE 118. MEXICO GENE-EDITING IN CROPS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
• TABLE 119. MEXICO GENE-EDITING IN CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
• TABLE 120. MEXICO GENE-EDITING IN CROPS MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
• TABLE 121. MEXICO GENE-EDITING IN CROPS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
• TABLE 122. MEXICO GENE-EDITING IN CROPS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
• TABLE 123. MEXICO GENE-EDITING IN CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 124. MEXICO GENE-EDITING IN CROPS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 125. MEXICO GENE-EDITING IN CROPS MARKET SIZE, BY DISEASE RESISTANCE, 2018-2024 (USD MILLION)
• TABLE 126. MEXICO GENE-EDITING IN CROPS MARKET SIZE, BY DISEASE RESISTANCE, 2025-2030 (USD MILLION)
• TABLE 127. MEXICO GENE-EDITING IN CROPS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 128. MEXICO GENE-EDITING IN CROPS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 129. BRAZIL GENE-EDITING IN CROPS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
• TABLE 130. BRAZIL GENE-EDITING IN CROPS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
• TABLE 131. BRAZIL GENE-EDITING IN CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
• TABLE 132. BRAZIL GENE-EDITING IN CROPS MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
• TABLE 133. BRAZIL GENE-EDITING IN CROPS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
• TABLE 134. BRAZIL GENE-EDITING IN CROPS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
• TABLE 135. BRAZIL GENE-EDITING IN CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 136. BRAZIL GENE-EDITING IN CROPS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 137. BRAZIL GENE-EDITING IN CROPS MARKET SIZE, BY DISEASE RESISTANCE, 2018-2024 (USD MILLION)
• TABLE 138. BRAZIL GENE-EDITING IN CROPS MARKET SIZE, BY DISEASE RESISTANCE, 2025-2030 (USD MILLION)
• TABLE 139. BRAZIL GENE-EDITING IN CROPS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 140. BRAZIL GENE-EDITING IN CROPS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 141. ARGENTINA GENE-EDITING IN CROPS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
• TABLE 142. ARGENTINA GENE-EDITING IN CROPS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
• TABLE 143. ARGENTINA GENE-EDITING IN CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
• TABLE 144. ARGENTINA GENE-EDITING IN CROPS MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
• TABLE 145. ARGENTINA GENE-EDITING IN CROPS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
• TABLE 146. ARGENTINA GENE-EDITING IN CROPS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
• TABLE 147. ARGENTINA GENE-EDITING IN CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 148. ARGENTINA GENE-EDITING IN CROPS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 149. ARGENTINA GENE-EDITING IN CROPS MARKET SIZE, BY DISEASE RESISTANCE, 2018-2024 (USD MILLION)
• TABLE 150. ARGENTINA GENE-EDITING IN CROPS MARKET SIZE, BY DISEASE RESISTANCE, 2025-2030 (USD MILLION)
• TABLE 151. ARGENTINA GENE-EDITING IN CROPS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 152. ARGENTINA GENE-EDITING IN CROPS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 153. EUROPE, MIDDLE EAST & AFRICA GENE-EDITING IN CROPS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
• TABLE 154. EUROPE, MIDDLE EAST & AFRICA GENE-EDITING IN CROPS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
• TABLE 155. EUROPE, MIDDLE EAST & AFRICA GENE-EDITING IN CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
• TABLE 156. EUROPE, MIDDLE EAST & AFRICA GENE-EDITING IN CROPS MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
• TABLE 157. EUROPE, MIDDLE EAST & AFRICA GENE-EDITING IN CROPS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
• TABLE 158. EUROPE, MIDDLE EAST & AFRICA GENE-EDITING IN CROPS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
• TABLE 159. EUROPE, MIDDLE EAST & AFRICA GENE-EDITING IN CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 160. EUROPE, MIDDLE EAST & AFRICA GENE-EDITING IN CROPS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 161. EUROPE, MIDDLE EAST & AFRICA GENE-EDITING IN CROPS MARKET SIZE, BY DISEASE RESISTANCE, 2018-2024 (USD MILLION)
• TABLE 162. EUROPE, MIDDLE EAST & AFRICA GENE-EDITING IN CROPS MARKET SIZE, BY DISEASE RESISTANCE, 2025-2030 (USD MILLION)
• TABLE 163. EUROPE, MIDDLE EAST & AFRICA GENE-EDITING IN CROPS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 164. EUROPE, MIDDLE EAST & AFRICA GENE-EDITING IN CROPS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 165. EUROPE, MIDDLE EAST & AFRICA GENE-EDITING IN CROPS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 166. EUROPE, MIDDLE EAST & AFRICA GENE-EDITING IN CROPS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
• TABLE 167. UNITED KINGDOM GENE-EDITING IN CROPS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
• TABLE 168. UNITED KINGDOM GENE-EDITING IN CROPS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
• TABLE 169. UNITED KINGDOM GENE-EDITING IN CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
• TABLE 170. UNITED KINGDOM GENE-EDITING IN CROPS MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
• TABLE 171. UNITED KINGDOM GENE-EDITING IN CROPS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
• TABLE 172. UNITED KINGDOM GENE-EDITING IN CROPS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
• TABLE 173. UNITED KINGDOM GENE-EDITING IN CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 174. UNITED KINGDOM GENE-EDITING IN CROPS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 175. UNITED KINGDOM GENE-EDITING IN CROPS MARKET SIZE, BY DISEASE RESISTANCE, 2018-2024 (USD MILLION)
• TABLE 176. UNITED KINGDOM GENE-EDITING IN CROPS MARKET SIZE, BY DISEASE RESISTANCE, 2025-2030 (USD MILLION)
• TABLE 177. UNITED KINGDOM GENE-EDITING IN CROPS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 178. UNITED KINGDOM GENE-EDITING IN CROPS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 179. GERMANY GENE-EDITING IN CROPS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
• TABLE 180. GERMANY GENE-EDITING IN CROPS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
• TABLE 181. GERMANY GENE-EDITING IN CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
• TABLE 182. GERMANY GENE-EDITING IN CROPS MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
• TABLE 183. GERMANY GENE-EDITING IN CROPS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
• TABLE 184. GERMANY GENE-EDITING IN CROPS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
• TABLE 185. GERMANY GENE-EDITING IN CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 186. GERMANY GENE-EDITING IN CROPS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 187. GERMANY GENE-EDITING IN CROPS MARKET SIZE, BY DISEASE RESISTANCE, 2018-2024 (USD MILLION)
• TABLE 188. GERMANY GENE-EDITING IN CROPS MARKET SIZE, BY DISEASE RESISTANCE, 2025-2030 (USD MILLION)
• TABLE 189. GERMANY GENE-EDITING IN CROPS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 190. GERMANY GENE-EDITING IN CROPS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 191. FRANCE GENE-EDITING IN CROPS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
• TABLE 192. FRANCE GENE-EDITING IN CROPS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
• TABLE 193. FRANCE GENE-EDITING IN CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
• TABLE 194. FRANCE GENE-EDITING IN CROPS MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
• TABLE 195. FRANCE GENE-EDITING IN CROPS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
• TABLE 196. FRANCE GENE-EDITING IN CROPS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
• TABLE 197. FRANCE GENE-EDITING IN CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 198. FRANCE GENE-EDITING IN CROPS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 199. FRANCE GENE-EDITING IN CROPS MARKET SIZE, BY DISEASE RESISTANCE, 2018-2024 (USD MILLION)
• TABLE 200. FRANCE GENE-EDITING IN CROPS MARKET SIZE, BY DISEASE RESISTANCE, 2025-2030 (USD MILLION)
• TABLE 201. FRANCE GENE-EDITING IN CROPS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 202. FRANCE GENE-EDITING IN CROPS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 203. RUSSIA GENE-EDITING IN CROPS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
• TABLE 204. RUSSIA GENE-EDITING IN CROPS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
• TABLE 205. RUSSIA GENE-EDITING IN CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
• TABLE 206. RUSSIA GENE-EDITING IN CROPS MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
• TABLE 207. RUSSIA GENE-EDITING IN CROPS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
• TABLE 208. RUSSIA GENE-EDITING IN CROPS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
• TABLE 209. RUSSIA GENE-EDITING IN CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 210. RUSSIA GENE-EDITING IN CROPS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 211. RUSSIA GENE-EDITING IN CROPS MARKET SIZE, BY DISEASE RESISTANCE, 2018-2024 (USD MILLION)
• TABLE 212. RUSSIA GENE-EDITING IN CROPS MARKET SIZE, BY DISEASE RESISTANCE, 2025-2030 (USD MILLION)
• TABLE 213. RUSSIA GENE-EDITING IN CROPS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 214. RUSSIA GENE-EDITING IN CROPS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 215. ITALY GENE-EDITING IN CROPS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
• TABLE 216. ITALY GENE-EDITING IN CROPS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
• TABLE 217. ITALY GENE-EDITING IN CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
• TABLE 218. ITALY GENE-EDITING IN CROPS MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
• TABLE 219. ITALY GENE-EDITING IN CROPS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
• TABLE 220. ITALY GENE-EDITING IN CROPS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
• TABLE 221. ITALY GENE-EDITING IN CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 222. ITALY GENE-EDITING IN CROPS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 223. ITALY GENE-EDITING IN CROPS MARKET SIZE, BY DISEASE RESISTANCE, 2018-2024 (USD MILLION)
• TABLE 224. ITALY GENE-EDITING IN CROPS MARKET SIZE, BY DISEASE RESISTANCE, 2025-2030 (USD MILLION)
• TABLE 225. ITALY GENE-EDITING IN CROPS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 226. ITALY GENE-EDITING IN CROPS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 227. SPAIN GENE-EDITING IN CROPS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
• TABLE 228. SPAIN GENE-EDITING IN CROPS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
• TABLE 229. SPAIN GENE-EDITING IN CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
• TABLE 230. SPAIN GENE-EDITING IN CROPS MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
• TABLE 231. SPAIN GENE-EDITING IN CROPS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
• TABLE 232. SPAIN GENE-EDITING IN CROPS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
• TABLE 233. SPAIN GENE-EDITING IN CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 234. SPAIN GENE-EDITING IN CROPS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 235. SPAIN GENE-EDITING IN CROPS MARKET SIZE, BY DISEASE RESISTANCE, 2018-2024 (USD MILLION)
• TABLE 236. SPAIN GENE-EDITING IN CROPS MARKET SIZE, BY DISEASE RESISTANCE, 2025-2030 (USD MILLION)
• TABLE 237. SPAIN GENE-EDITING IN CROPS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 238. SPAIN GENE-EDITING IN CROPS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 239. UNITED ARAB EMIRATES GENE-EDITING IN CROPS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
• TABLE 240. UNITED ARAB EMIRATES GENE-EDITING IN CROPS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
• TABLE 241. UNITED ARAB EMIRATES GENE-EDITING IN CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
• TABLE 242. UNITED ARAB EMIRATES GENE-EDITING IN CROPS MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
• TABLE 243. UNITED ARAB EMIRATES GENE-EDITING IN CROPS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
• TABLE 244. UNITED ARAB EMIRATES GENE-EDITING IN CROPS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
• TABLE 245. UNITED ARAB EMIRATES GENE-EDITING IN CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 246. UNITED ARAB EMIRATES GENE-EDITING IN CROPS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 247. UNITED ARAB EMIRATES GENE-EDITING IN CROPS MARKET SIZE, BY DISEASE RESISTANCE, 2018-2024 (USD MILLION)
• TABLE 248. UNITED ARAB EMIRATES GENE-EDITING IN CROPS MARKET SIZE, BY DISEASE RESISTANCE, 2025-2030 (USD MILLION)
• TABLE 249. UNITED ARAB EMIRATES GENE-EDITING IN CROPS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 250. UNITED ARAB EMIRATES GENE-EDITING IN CROPS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 251. SAUDI ARABIA GENE-EDITING IN CROPS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
• TABLE 252. SAUDI ARABIA GENE-EDITING IN CROPS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
• TABLE 253. SAUDI ARABIA GENE-EDITING IN CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
• TABLE 254. SAUDI ARABIA GENE-EDITING IN CROPS MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
• TABLE 255. SAUDI ARABIA GENE-EDITING IN CROPS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
• TABLE 256. SAUDI ARABIA GENE-EDITING IN CROPS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
• TABLE 257. SAUDI ARABIA GENE-EDITING IN CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 258. SAUDI ARABIA GENE-EDITING IN CROPS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 259. SAUDI ARABIA GENE-EDITING IN CROPS MARKET SIZE, BY DISEASE RESISTANCE, 2018-2024 (USD MILLION)
• TABLE 260. SAUDI ARABIA GENE-EDITING IN CROPS MARKET SIZE, BY DISEASE RESISTANCE, 2025-2030 (USD MILLION)
• TABLE 261. SAUDI ARABIA GENE-EDITING IN CROPS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 262. SAUDI ARABIA GENE-EDITING IN CROPS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 263. SOUTH AFRICA GENE-EDITING IN CROPS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
• TABLE 264. SOUTH AFRICA GENE-EDITING IN CROPS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
• TABLE 265. SOUTH AFRICA GENE-EDITING IN CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
• TABLE 266. SOUTH AFRICA GENE-EDITING IN CROPS MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
• TABLE 267. SOUTH AFRICA GENE-EDITING IN CROPS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
• TABLE 268. SOUTH AFRICA GENE-EDITING IN CROPS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
• TABLE 269. SOUTH AFRICA GENE-EDITING IN CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 270. SOUTH AFRICA GENE-EDITING IN CROPS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 271. SOUTH AFRICA GENE-EDITING IN CROPS MARKET SIZE, BY DISEASE RESISTANCE, 2018-2024 (USD MILLION)
• TABLE 272. SOUTH AFRICA GENE-EDITING IN CROPS MARKET SIZE, BY DISEASE RESISTANCE, 2025-2030 (USD MILLION)
• TABLE 273. SOUTH AFRICA GENE-EDITING IN CROPS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 274. SOUTH AFRICA GENE-EDITING IN CROPS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 275. DENMARK GENE-EDITING IN CROPS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
• TABLE 276. DENMARK GENE-EDITING IN CROPS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
• TABLE 277. DENMARK GENE-EDITING IN CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
• TABLE 278. DENMARK GENE-EDITING IN CROPS MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
• TABLE 279. DENMARK GENE-EDITING IN CROPS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
• TABLE 280. DENMARK GENE-EDITING IN CROPS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
• TABLE 281. DENMARK GENE-EDITING IN CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 282. DENMARK GENE-EDITING IN CROPS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 283. DENMARK GENE-EDITING IN CROPS MARKET SIZE, BY DISEASE RESISTANCE, 2018-2024 (USD MILLION)
• TABLE 284. DENMARK GENE-EDITING IN CROPS MARKET SIZE, BY DISEASE RESISTANCE, 2025-2030 (USD MILLION)
• TABLE 285. DENMARK GENE-EDITING IN CROPS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 286. DENMARK GENE-EDITING IN CROPS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 287. NETHERLANDS GENE-EDITING IN CROPS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
• TABLE 288. NETHERLANDS GENE-EDITING IN CROPS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
• TABLE 289. NETHERLANDS GENE-EDITING IN CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
• TABLE 290. NETHERLANDS GENE-EDITING IN CROPS MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
• TABLE 291. NETHERLANDS GENE-EDITING IN CROPS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
• TABLE 292. NETHERLANDS GENE-EDITING IN CROPS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
• TABLE 293. NETHERLANDS GENE-EDITING IN CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 294. NETHERLANDS GENE-EDITING IN CROPS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 295. NETHERLANDS GENE-EDITING IN CROPS MARKET SIZE, BY DISEASE RESISTANCE, 2018-2024 (USD MILLION)
• TABLE 296. NETHERLANDS GENE-EDITING IN CROPS MARKET SIZE, BY DISEASE RESISTANCE, 2025-2030 (USD MILLION)
• TABLE 297. NETHERLANDS GENE-EDITING IN CROPS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 298. NETHERLANDS GENE-EDITING IN CROPS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 299. QATAR GENE-EDITING IN CROPS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
• TABLE 300. QATAR GENE-EDITING IN CROPS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
• TABLE 301. QATAR GENE-EDITING IN CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
• TABLE 302. QATAR GENE-EDITING IN CROPS MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
• TABLE 303. QATAR GENE-EDITING IN CROPS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
• TABLE 304. QATAR GENE-EDITING IN CROPS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
• TABLE 305. QATAR GENE-EDITING IN CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 306. QATAR GENE-EDITING IN CROPS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 307. QATAR GENE-EDITING IN CROPS MARKET SIZE, BY DISEASE RESISTANCE, 2018-2024 (USD MILLION)
• TABLE 308. QATAR GENE-EDITING IN CROPS MARKET SIZE, BY DISEASE RESISTANCE, 2025-2030 (USD MILLION)
• TABLE 309. QATAR GENE-EDITING IN CROPS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 310. QATAR GENE-EDITING IN CROPS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 311. FINLAND GENE-EDITING IN CROPS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
• TABLE 312. FINLAND GENE-EDITING IN CROPS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
• TABLE 313. FINLAND GENE-EDITING IN CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
• TABLE 314. FINLAND GENE-EDITING IN CROPS MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
• TABLE 315. FINLAND GENE-EDITING IN CROPS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
• TABLE 316. FINLAND GENE-EDITING IN CROPS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
• TABLE 317. FINLAND GENE-EDITING IN CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 318. FINLAND GENE-EDITING IN CROPS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 319. FINLAND GENE-EDITING IN CROPS MARKET SIZE, BY DISEASE RESISTANCE, 2018-2024 (USD MILLION)
• TABLE 320. FINLAND GENE-EDITING IN CROPS MARKET SIZE, BY DISEASE RESISTANCE, 2025-2030 (USD MILLION)
• TABLE 321. FINLAND GENE-EDITING IN CROPS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 322. FINLAND GENE-EDITING IN CROPS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 323. SWEDEN GENE-EDITING IN CROPS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
• TABLE 324. SWEDEN GENE-EDITING IN CROPS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
• TABLE 325. SWEDEN GENE-EDITING IN CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)

The Gene-Editing in Crops Market was valued at USD 2.49 billion in 2024 and is projected to grow to USD 2.76 billion in 2025, with a CAGR of 11.47%, reaching USD 4.77 billion by 2030.

Exploring the Frontiers of Crop Innovation Through Gene-Editing Technologies to Strengthen Food Security and Drive Sustainable Agricultural Transformation

The emergence of precision gene-editing techniques represents a pivotal moment in agricultural science, offering unprecedented opportunities to address global food security challenges. As the world's population continues to grow and climates become more unpredictable, traditional breeding methods alone cannot deliver the rapid improvements in yield, resilience, and nutritional quality that modern societies demand. Gene-editing platforms such as CRISPR-based systems, base editing, and prime editing are redefining the toolkit available to researchers and developers, enabling precise, efficient, and cost-effective modifications of key crop traits.

Furthermore, regulatory environments are evolving to accommodate these novel technologies, creating a dynamic landscape that balances innovation with safety and public acceptance. Across regions, policymakers are revisiting frameworks to support responsible development, while consumer advocacy groups and industry stakeholders engage in constructive dialogue regarding transparency and labelling. As a result, the pathway to commercial deployment is becoming clearer, yet challenges remain in harmonizing standards and ensuring equitable access to cutting-edge solutions.

This report offers a comprehensive introduction to the latest advancements in crop gene-editing, the transformative shifts underway, the implications of recent tariff policies in the United States, and the strategic segmentation critical for investors and decision-makers. It also provides regional analyses, company profiles, and actionable recommendations designed to empower industry leaders. By weaving together technological, regulatory, and market perspectives, this introduction sets the stage for an in-depth exploration of how gene-editing is poised to revolutionize crop development and sustainability.

Unveiling the Paradigm Shifts Reshaping Crop Genetics Through Breakthrough Innovations and Evolving Regulatory Dynamics in Agriculture

Over the past decade, the agricultural sector has undergone a series of transformative shifts driven by breakthroughs in molecular biology, advances in data analytics, and shifting regulatory priorities. The rapid refinement of CRISPR-Cas tools and the emergence of next-generation editing systems have accelerated the pace at which novel crop varieties can be developed. In parallel, rising consumer demand for healthier, more nutritious produce has prompted companies to integrate genome editing into their product pipelines, targeting traits such as enhanced vitamin levels and improved flavor profiles.

Moreover, policy changes in major markets have catalyzed investment and collaboration. Progressive frameworks in certain regions have reduced approval timelines for gene-edited crops, encouraging public-private partnerships and pilot programs that demonstrate real-world benefits. At the same time, environmental imperatives have elevated the importance of drought tolerance and disease resistance, spurring research into gene-enabled solutions that can reduce reliance on agrochemicals and preserve biodiversity.

Consequently, the landscape of crop genetics is evolving from a fragmented array of experimental initiatives toward a cohesive innovation ecosystem. Universities, research institutes, and seed developers are establishing consortiums, sharing best practices, and harmonizing protocols to overcome technical bottlenecks. With these structural changes in place, the stage is set for gene-editing to emerge as a mainstream driver of agricultural productivity and resilience.

Assessing the Far-Reaching Consequences of New United States Tariffs on Gene-Edited Crop Development Supply Chains and Global Trade Flows

In 2025, the introduction of new tariff measures by the United States has the potential to reshape global supply chains for gene-edited seeds and associated inputs. By imposing additional duties on imported reagents, specialized enzymes, and custom delivery systems, these policies may raise the cost of research and development for both domestic and international stakeholders. As a result, companies may reassess production locations, procurement strategies, and partnership agreements to mitigate rising expenses.

The ripple effects extend beyond laboratory budgets. Seed producers that rely on global sourcing of gene-editing components could face extended lead times, prompting strategic stockpiling or the diversification of supplier networks. Similarly, collaborative projects between academic institutions in the United States and technology providers abroad may require renegotiation of terms to address tariff-induced financial uncertainties. In the long term, these shifts may encourage vertical integration, with larger firms pursuing in-house capabilities to reduce exposure to external cost fluctuations.

However, opportunities emerge for domestic manufacturers of reagents and instrumentation, who may experience increased demand as companies seek to localize supply chains. This dynamic could foster innovation in manufacturing processes and drive competitive differentiation through quality, speed, and service. Ultimately, the cumulative impact of tariff policies will hinge on the ability of stakeholders to adapt procurement strategies, invest in supply-chain resilience, and cultivate new partnerships that balance cost and capability.

Dissecting the Gene-Editing Crop Market Through Comprehensive Strategic Multi-Dimensional Segmentation Lenses for Actionable Insights

The gene-editing landscape can be dissected through multiple dimensions of analysis, each shedding light on distinct value drivers and investment priorities. When viewed through the lens of technology platform, the spectrum ranges from base editing and prime editing to CRISPR-based systems, meganucleases, site-directed nucleases, transcription activator-like effector nucleases, and zinc finger nucleases, each offering unique benefits in precision and off-target risk management. Shifting focus to crop type reveals differentiated opportunities across cereal grains, fruits and vegetables, legumes and pulses, and oilseed crops, which respond variably to genetic enhancements aimed at yield, pest resistance, and nutritional content.

Delivery method provides yet another vantage point, encompassing established approaches such as Agrobacterium-mediated transformation and electroporation alongside emerging techniques like gene gun, nanoparticle-based delivery, ribonucleoprotein complexes, and viral vector delivery, each with implications for efficiency, regulatory acceptance, and field performance. Applications of gene editing further refine the narrative, illustrating how traits for disease resistance-spanning bacterial, fungal, and viral challenges-coalesce with drought tolerance, herbicide tolerance, and nutritional enhancement to address both agronomic and consumer needs.

Finally, end-user segmentation brings clarity to commercialization pathways, highlighting the roles of agricultural biotechnology companies, farmers and grower associations, government and regulatory bodies, research institutes and universities, and seed companies in driving adoption. By integrating these segmentation lenses, stakeholders can identify high-value intersections, prioritize R&D investments, and align strategies with end-market demands.

Mapping the Regional Dynamics of Gene-Editing Crop Adoption Across Key Global Territories to Uncover Strategic Growth Opportunities

Regional market dynamics reveal a tapestry of divergent regulatory approaches, research intensity, and adoption rates. In the Americas, robust private-sector investment and streamlined regulatory pathways in key markets have accelerated the commercialization of gene-edited crop varieties, while smaller economies in the region continue to establish foundational policies and infrastructure. Conversely, in Europe, Middle East & Africa, a more cautious stance driven by rigorous safety assessments coexists with pockets of innovation in research hubs that focus on trait development for climate resilience.

Transitioning to the Asia-Pacific region, a convergence of governmental support programs, agrarian demographics, and escalating food security pressures has led to an enthusiastic pursuit of gene-editing solutions. National research initiatives and university collaborations are forging public-private partnerships aimed at tailoring innovations to local varietals and environmental conditions. Meanwhile, nascent markets in Southeast Asia are balancing rapid adoption desires with the need to build capacity in regulatory science and biosafety evaluation.

Together, these regional narratives underscore the importance of market-specific strategies in research prioritization, stakeholder engagement, and policy advocacy. Understanding the distinctive currents in each geography enables companies to tailor their approaches, optimize trial frameworks, and navigate complex approval processes with greater confidence.

Highlighting the Leading Innovators and Strategic Collaborators Shaping the Gene-Editing Crop Ecosystem Through Pioneering Research and Partnerships

Leading organizations in the gene-editing crop sector epitomize innovation through diversified research pipelines and strategic collaborations. Established agricultural biotechnology firms are leveraging decades of expertise in molecular breeding to integrate gene-editing tools, forming alliances with specialized technology providers to enhance trait discovery and validation. Meanwhile, emerging biotech startups are carving out niches by focusing on high-impact applications such as enhanced nutritional profiles or next-generation resistance to pathogens.

Partnerships between seed companies and academic institutions have become increasingly common, fostering knowledge exchange and shared access to cutting-edge platforms. This collaborative model accelerates trait commercialization while distributing the risk and cost of early-stage research. Concurrently, technology providers that supply reagents, instrumentation, and bioinformatics services are expanding their portfolios to support end-to-end pipelines, from target identification through regulatory dossier preparation.

Investor interest has also reshaped the competitive landscape, with venture capital and strategic corporate funding driving the emergence of hybrid entities that blend startup agility with institutional resources. Together, these leading players are establishing best practices for intellectual property management, regulatory engagement, and commercialization pathways, laying the groundwork for sustained innovation and market penetration across diverse crop segments.

Empowering Industry Stakeholders with Strategic Recommendations to Accelerate Development and Adoption of Gene-Editing Technologies in Agriculture

Industry stakeholders should prioritize the early integration of regulatory intelligence into research planning to streamline approval pathways and avoid costly delays. Cultivating relationships with policy makers and aligning on transparent safety frameworks can facilitate smoother market entry and build public trust. Moreover, investing in scalable delivery platforms-such as nanoparticle-based systems or ribonucleoprotein complexes-can reduce time to field trials and enhance the precision of genetic modifications.

In parallel, companies are advised to develop diversified pipelines that balance high-value, short-term opportunities like herbicide tolerance with longer-term, high-impact traits such as drought resilience and nutritional enhancement. Such dual-track strategies can optimize resource allocation and mitigate the risk of single-product dependencies. Additionally, forging consortiums between seed companies, research institutes, and technology providers can accelerate trait validation and share infrastructure costs, enabling smaller players to compete effectively.

Finally, embracing digital tools for data management and bioinformatics will be critical in extracting maximum value from genotype-phenotype insights. By deploying machine learning algorithms and robust data-analytics platforms, organizations can prioritize candidate edits, predict off-target effects, and refine breeding strategies with greater speed and accuracy. Collectively, these actions will empower leaders to navigate complexity, unlock new growth avenues, and reinforce their competitive edge.

Unveiling the Rigorous Research Methodology Underpinning the Comprehensive Analysis of Gene-Editing Innovations in Crop Science

This analysis is grounded in a rigorous research methodology that synthesizes primary insights with secondary data sources. Expert interviews with seasoned researchers, regulatory specialists, and industry executives were conducted to capture nuanced perspectives on technological feasibility, policy evolution, and commercialization strategies. These qualitative findings were systematically triangulated against published scientific literature, patent filings, and government publications to ensure both depth and accuracy.

Secondary research encompassed a comprehensive review of peer-reviewed journals, conference proceedings, and regulatory guidelines from major jurisdictions. Critical data points were validated through cross-referencing multiple credible sources, enabling a holistic understanding of gene-editing platforms and application trends. Information on delivery methods, trait development, and end-user adoption was analyzed to reveal emerging patterns and potential inflection points.

Furthermore, the study incorporated trend analyses of collaborative initiatives, funding flows, and academic-industry partnerships, highlighting the interplay between innovation ecosystems and commercial deployment. By integrating both macro-level observations and granular project-level case studies, the methodology provides a balanced framework for capturing the multifaceted dynamics of crop gene-editing.

Synthesizing Key Insights and Charting the Future Trajectory of Crop Gene-Editing for Sustained Innovation and Food Security Advancement

This executive summary brings together critical insights across technological advances, regulatory shifts, tariff implications, and strategic segmentation within the gene-editing crop arena. It highlights how diverse editing platforms are converging with evolving policy frameworks to accelerate the development of crops with improved resilience, productivity, and nutritional value. The analysis underscores the nuanced regional dynamics that shape adoption pathways, from the robust private-sector engagement in the Americas to the collaborative public-private models in the Asia-Pacific region.

Key segmentation perspectives offer a roadmap for prioritizing research and commercialization efforts, revealing how technology platforms, crop types, delivery methods, application areas, and end-user profiles intersect to create high-value opportunities. Insights into leading companies illustrate the importance of strategic partnerships, diversified pipelines, and integrated data analytics for sustaining innovation.

By synthesizing these findings, the conclusion affirms that gene-editing is poised to redefine modern agriculture. Stakeholders equipped with a deep understanding of strategic imperatives, regional nuances, and actionable recommendations will be well positioned to capitalize on this transformative wave and contribute to global food security objectives.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Market Sizing & Forecasting

5. Market Dynamics

• 5.1. Integration of multiplexed gene-editing platforms to develop disease resistant tomato and potato varieties
• 5.2. Accelerating adoption of CRISPR base editors to improve drought and heat tolerance in staple crops
• 5.3. Commercialization strategies for gene-edited soybeans targeting increased protein content and nitrogen use efficiency
• 5.4. Advancements in tissue-specific promoter design enabling precise gene edits for pest resistance in maize
• 5.5. Regulatory harmonization efforts between the US, EU and Asia Pacific for gene-editing approvals in agriculture biotechnology
• 5.6. Collaborations between agri-biotech startups and academic institutions to accelerate wheat genome editing pipeline
• 5.7. Investment surge in predictive phenotyping and AI-driven target identification for optimized gene edits in rice

6. Market Insights

• 6.1. Porter's Five Forces Analysis
• 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Gene-Editing in Crops Market, by Technology Platform

• 8.1. Introduction
• 8.2. Base Editing & Prime Editing
• 8.3. CRISPR-based systems
• 8.4. Meganucleases
• 8.5. Site-Directed Nucleases
• 8.6. Transcription Activator-Like Effector Nucleases
• 8.7. Zinc Finger Nucleases

9. Gene-Editing in Crops Market, by Crop Type

• 9.1. Introduction
• 9.2. Cereal Crops
• 9.3. Fruits & Vegetables
• 9.4. Legumes & Pulses
• 9.5. Oilseed Crops

10. Gene-Editing in Crops Market, by Delivery Method

• 10.1. Introduction
• 10.2. Agrobacterium-Mediated Transformation
• 10.3. Electroporation
• 10.4. Gene Gun
• 10.5. Nanoparticle-Based Delivery
• 10.6. Ribonucleoprotein (RNP) Complexes
• 10.7. Viral Vector Delivery

11. Gene-Editing in Crops Market, by Application

• 11.1. Introduction
• 11.2. Disease Resistance
  • 11.2.1. Bacterial Resistance
  • 11.2.2. Fungal Resistance
  • 11.2.3. Viral Resistance
• 11.3. Drought Tolerance
• 11.4. Herbicide Tolerance
• 11.5. Nutritional Enhancement

12. Gene-Editing in Crops Market, by End-User

• 12.1. Introduction
• 12.2. Agricultural Biotechnology Companies
• 12.3. Farmers & Grower Associations
• 12.4. Government & Regulatory Bodies
• 12.5. Research Institutes & Universities
• 12.6. Seed Companies

13. Americas Gene-Editing in Crops Market

• 13.1. Introduction
• 13.2. United States
• 13.3. Canada
• 13.4. Mexico
• 13.5. Brazil
• 13.6. Argentina

14. Europe, Middle East & Africa Gene-Editing in Crops Market

• 14.1. Introduction
• 14.2. United Kingdom
• 14.3. Germany
• 14.4. France
• 14.5. Russia
• 14.6. Italy
• 14.7. Spain
• 14.8. United Arab Emirates
• 14.9. Saudi Arabia
• 14.10. South Africa
• 14.11. Denmark
• 14.12. Netherlands
• 14.13. Qatar
• 14.14. Finland
• 14.15. Sweden
• 14.16. Nigeria
• 14.17. Egypt
• 14.18. Turkey
• 14.19. Israel
• 14.20. Norway
• 14.21. Poland
• 14.22. Switzerland

15. Asia-Pacific Gene-Editing in Crops Market

• 15.1. Introduction
• 15.2. China
• 15.3. India
• 15.4. Japan
• 15.5. Australia
• 15.6. South Korea
• 15.7. Indonesia
• 15.8. Thailand
• 15.9. Philippines
• 15.10. Malaysia
• 15.11. Singapore
• 15.12. Vietnam
• 15.13. Taiwan

16. Competitive Landscape

• 16.1. Market Share Analysis, 2024
• 16.2. FPNV Positioning Matrix, 2024
• 16.3. Competitive Analysis
  • 16.3.1. AgBiome, Inc.
  • 16.3.2. BASF SE
  • 16.3.3. Bayer AG
  • 16.3.4. Benson Hill, Inc.
  • 16.3.5. Calyxt, Inc.
  • 16.3.6. Cibus, Inc.
  • 16.3.7. Corteva Agriscience, Inc. by DuPont de Nemours, Inc
  • 16.3.8. Creative Biogene
  • 16.3.9. Elo Life Systems
  • 16.3.10. Groupe Limagrain S.A.
  • 16.3.11. Inari Agriculture, Inc.
  • 16.3.12. KWS SAAT SE & Co. KGaA
  • 16.3.13. Origin Agritech
  • 16.3.14. Pairwise Foods, Inc.
  • 16.3.15. Syngenta AG
  • 16.3.16. Yield10 Bioscience, Inc.

17. ResearchAI

18. ResearchStatistics

19. ResearchContacts

20. ResearchArticles

21. Appendix